Scarica l'app Stockscreener
35.72
0.12%
-0.0441
Dopo l'orario di chiusura:
35.65
-0.0677
-0.19%
Precedente Chiudi:
$35.76
Aprire:
$35.76
Volume 24 ore:
5,918
Relative Volume:
0.17
Capitalizzazione di mercato:
$N/A
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-0.08%
1M Prestazione:
-4.81%
6M Prestazione:
+30.96%
1 anno Prestazione:
+46.05%
Intervallo 1D:
$35.55
$36.02
Intervallo di 1 settimana:
$34.60
$36.06
Portata 52W:
$20.10
$38.34
Tema Oncology Etf Stock (CANC) Company Profile
Nome
Tema Oncology Etf
Settore
Industria
Telefono
-
Indirizzo
-
Compare CANC vs VTI, SPY, IVV, VB, QQQ
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CANC
Tema Oncology Etf
|
35.72 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
319.55 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
State Street Spdr S P 500 Etf Trust
|
645.09 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
648.01 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
261.74 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
573.79 | 124.43B | 0 | 0 | 0 | 0.00 |
Tema Oncology Etf Borsa (CANC) Ultime notizie
(CANC) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Biotech stocks and longevity investing: Trends to track - North Scott Press
CANC Stock Chart | TEMA ONCOLOGY ETF (NASDAQ:CANC) - ChartMill
Why Is Cogent Biosciences Stock Surging Monday?Cogent Biosciences (NASDAQ:COGT) - Benzinga
Land and Houses Asset Management launches LHLONGEVITY, investing in innovative cancer treatment stocks. - วารสารการเงินธนาคาร
Cogent Biosciences Stock Climbs After FDA Accepts Key Drug Application - Sahm
This Investor Built a $56 Million Position in RAPT Last Quarter. It Was Just Acquired for $58 Per Share - AOL.com
ETFs Investing in Adlai Nortye Ltd. Sponsored ADR Stocks - TradingView
How (CANC) Movements Inform Risk Allocation Models - Stock Traders Daily
2 Under-the-Radar Stocks to Buy and Hold - AOL.com
Healthcare stocks are red-hot. Here are 3 picks from a fund manager up 41% this year. - MSN
GNOM, CANC, IBB: Use Targeted Healthcare ETFs to Build Wealth - TipRanks
F/m High Yield 100 ETF (NASDAQ:ZTOP) Shares Down 0.2% – Time to Sell? - Defense World
Trading Systems Reacting to (CANC) Volatility - Stock Traders Daily
11 Best Cancer Stocks to Invest In Now - Insider Monkey
How Tema Oncology Etf (CANC) Affects Rotational Strategy Timing - Stock Traders Daily
Thrivent Financial for Lutherans Decreases Stake in Tema Oncology ETF $CANC - Defense World
(CANC) and the Role of Price-Sensitive Allocations - Stock Traders Daily
2 Stocks That Could Soar This Year - AOL.com
This Top Dividend Stock Could Achieve a Major Milestone This Year. Is It a Buy? - AOL.com
Responsive Playbooks and the CANC Inflection - Stock Traders Daily
Understanding the Setup: (CANC) and Scalable Risk - Stock Traders Daily
Tema Oncology ETF (NQ: CANC - FinancialContent
Here's Why Biotech ETFs Are Rallying Hard - Zacks Investment Research
Los Angeles Daily NewsTema Oncology ETF (Nasdaq:CANC) Stock Quote - FinancialContent
The Technical Signals Behind (CANC) That Institutions Follow - Stock Traders Daily
Biotech Market Forecast: Top Trends for Biotech in 2026 - Investing News Network
Avoiding Lag: Real-Time Signals in (CANC) Movement - Stock Traders Daily
ETFs Investing in Ascentage Pharma Group International Unsponsored ADR Stocks - TradingView — Track All Markets
Discipline and Rules-Based Execution in CANC Response - news.stocktradersdaily.com
Tema’s Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance - PharmiWeb.com
The AI Pharma Rally Is Real — And Cancer May Soon Be Chronic, Not Deadly - Sahm
Be Thankful to These ETFs This Year - sharewise.com
Behavioral Patterns of CANC and Institutional Flows - news.stocktradersdaily.com
Inside the Recent Strength in Biotech ETFs - TradingView
Biotech ETFs Bounce Back in 2025: Here's Why - sharewise.com
Aug PostEarnings: Is Tema ETF Trust Tema International stock among top earnings playsInsider Selling & Reliable Volume Spike Trade Alerts - nchmf.gov.vn
5 Small-cap Biotech ETFs to Watch in 2025 - Investing News Network
ETFs with Bristol-Myers Squibb Company ( BMY ) Exposure - ETF Database
Tema Launches Alternative Asset Managers ETF (AAUM) - Business Wire
What hedge fund moves indicate for Tema ETF Trust Tema Monopolies stockLayoff News & Growth Focused Stock Reports - newser.com
Tema Launches First International Defense Innovation ETF (GDFN) - Business Wire
2 Growth Stocks to Buy and Hold Forever - AOL.com
Tema Launches International Durable Quality ETF (ITOL) - Business Wire
Tema Surpasses $1bn AUM Two Years After Launch, Strengthens Team With Key Growth Hires - Business Wire
Tema Announces Liquidation of Two ETFs - Business Wire
5 Small-cap Biotech ETFs to Watch - Nasdaq
Bristol-Myers Squibb At ASCO 2025: A Resilient Play Amid Market Turbulence (NYSE:BMY) - Seeking Alpha
Biotech Outperformance: Can’t Take What’s Already Earned - Seeking Alpha
Tema Launches the S&P 500 Historical Weight ETF Strategy (DSPY), First S&P 500 Concentration Innovation Since 2003 - Business Wire
AAPG Stock Price and Chart — NASDAQ:AAPG - TradingView
Tema Oncology Etf Azioni (CANC) Dati Finanziari
Non sono disponibili dati finanziari per Tema Oncology Etf (CANC). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):